“Our goal is to bridge the gap between laboratory discoveries and affordable cancer diagnostics — making early detection accessible to every patient, regardless of where they live.”
Research
The Problem
Cervical cancer remains the second most common cancer among Indian women, while colorectal cancer incidence is rising rapidly — particularly early-onset CRC in younger populations. Current screening tools are often expensive, require specialized infrastructure, and are inaccessible to the majority of India's population. The gut microbiome's role in cancer development is poorly understood in Indian populations, where dietary patterns, genetics, and microbial exposures differ significantly from Western cohorts.
The Approach
Dr. Bose's laboratory employs a multi-pronged translational research strategy: developing affordable biomarker-based screening tools (DAS-ELISA for HPV/p16 detection), characterizing the colorectal cancer-associated gut microbiome using 16S rRNA gene sequencing and whole metagenome analysis, and building international research networks to compare microbial patterns across populations. The lab collaborates with institutions in the UK, Chile, Argentina, and Vietnam through GCRF-funded networks, and coordinates a 12-center pan-India consortium (PEACOCC) to study early-onset CRC. Machine learning models are being applied to microbiome data for predictive diagnostics.
Innovations & Discoveries
The p16 DAS-ELISA technology for cervical cancer screening was successfully developed and transferred to HLL Lifecare Limited — a Government of India Enterprise — for large-scale manufacturing and deployment. Gut microbiome profiling has revealed that India-specific CRC microbiome signatures show geographic distinctness but share universal CRC-associated patterns with UK cohorts. A notable finding from the international E. coli (pks+) study showed 4% prevalence in Indian CRC patients compared to 31% in the UK NHSBCSP cohort, suggesting distinct genotoxic mechanisms. The PEACOCC consortium is generating the first comprehensive characterization of early-onset CRC microbial composition across India.
MolOnco-DnT-CenTr: Molecular Oncology Diagnostics & Therapeutics Centre
Ongoing
Funding: ICMR-CAR
Role: Site-PI
Awards & Achievements
Young Immunologists from the Developing World Award — International Union of Immunological Societies (IUIS)
Technology Transfer: p16 DAS-ELISA to HLL Lifecare Limited, Government of India Enterprise
DHR-ICMR International Fellow (2025–2026)
Our Team
Selected Publications
Gut microbiome in Indian and UK colorectal cancer shows geographic differences but universal CRC-associated patterns
Thomas J, Ohlsson L, Sena M, Kumar V, Nair S, Kalarani D, Aishwarya P, Singarayer de Sylva A, Priya VM, Bose M, Quirke P, Hasan S, Sejnova D, Vymetalkova V, Vodickova L, Brennan P, Vodicka P, Sillo T, and Cross A